Why Assembly Biosciences Stock Crashed Today

Shares of Assembly Biosciences (NASDAQ: ASMB) crashed on Friday, plunging 69.4% as of the market close. The huge drop came after the company announced disappointing results Thursday evening from a phase 2 study evaluating vebicorvir (VBR) in treating patients with chronic hepatitis B virus (HBV) infection.

Clinical failures for lead pipeline candidates always cause biotech stocks to plummet. Assembly Biosciences' crash today is just the latest example.

Image source: Getty Images.

Continue reading

Source Fool.com